早期糖尿病视网膜病变药物治疗的药物经济学分析
 |
| 第1页 |
参见附件。
[摘要] 目的:探讨不同方案治疗早期糖尿病视网膜病变的经济效果,找出既经济又有效的方案。方法:对目前临床常用的4种不同治疗方案(导升明、胰激肽原酶、复方血栓通胶囊、复方丹参滴丸,治疗时间均为90 d)运用药物经济学方法进行成本-效果分析。结果:4种方案所需费用分别为1 417.50元、810.00元、891.00元、656.10元;治疗有效率分别为94.25%、85.09%、85.17%、83.53%;成本-效果比分别为15.04、9.52、10.46、7.85。结论:复方丹参滴丸治疗效果较好,不良反应少,成本低廉。
[关键词] 早期糖尿病视网膜病变;成本-效果分析;药物经济学
[中图分类号] R956[文献标识码]C [文章编号]1673-7210(2010)02(c)-137-02
Pharmacoeconomics analysis of medical treatment for early diabetic retinopathy
XU Nanxiang
(Jiangdu Medical Insurance Management Agency, Jiangsu Province, Jiangdu 225200, China)
[Abstract] Objective: To explore the costs of different treatments for curing early diabetic retinopathy, in order to find out a most economical and effective method. Methods: The current commonly used four different treatment programs (Doxium Tablets, Kallikrein, Fufang Xueshuantong Capsule and Compound Danshen Dripping Pills, the treatment times were 90 days) were performed by cost-effectiveness analysis in pharmacoeconomics. Results: The costs of these four treatments were 1 417.50 yuan, 810.00 yuan, 891.00 yuan, 656 ......
您现在查看是摘要介绍页，详见PDF附件。